Expanding the depth and breadth of scientific expertise that defines Stem Cell Reports, the official journal of the International Society for Stem Cell Research, 13 distinguished researchers have joined the Editorial Board. Their appointment broadens representation across the diverse and international landscape of stem cell science and reinforces the Board’s commitment to championing the journal, raising its global visibility, and ensuring rigorous, high-quality peer review.
“I am delighted to welcome our new editorial board members to Stem Cell Reports, said Janet Rossant, editor-in-chief. “Their breadth of expertise – spanning basic biology, translational research, clinical application, and ethical considerations – reflects the rich diversity of the global stem cell community. Together, we will continue to ensure that the journal serves as a leading platform for high-quality science that informs, inspires, and advances our field.”
The new Stem Cell Reports Editorial Board members include:
Bertie Göttgens, Cambridge Stem Cell Institute, UK
Shimpei Gotoh, Center for iPS Cell Research and Application, Japan
Kristin Hope, University Health Network’s Princess Margaret Cancer Centre, Canada
Rosario Isasi, University of Miami, USA
Darrel Kotton, Boston University Chobanian & Avedisian School of Medicine, USA
Feng Liu, Shandong University/Chinese Academy of Sciences, China
Zubin Master, Wake Forest University, USA
Elizabeth Ng, Murdoch Children’s Research Institute, Australia
Nathan Palpant, The University of Queensland, Australia
Olivier Pourquie, Harvard Medical School/Brigham and Women’s Hospital, USA
Thomas Rando, University of California, Los Angeles, USA
Yonatan Stelzer, Weizmann Institute of Science, Israel
Thor Theunissen, Washington University School of Medicine, USA
The addition of the new board members further strengthens the journal and provides support to the editorial team, which includes five prominent associate editors:
Anne Grapin-Botton, Max Planck Institute of Molecular Cell Biology and Genetics, Germany, investigates how pancreatic cells differentiate and regenerate, with a focus on the influence of tissue architecture on cell fate decisions.
Haruhisa Inoue, Kyoto University, Japan, is a physician-scientist pioneering iPSC-based models and clinical trials for neurodegenerative diseases, including ALS and Alzheimer’s disease.
Martin Pera, The Jackson Laboratory, USA, is a leader in human pluripotent stem cell biology whose research spans self-renewal, pluripotency, and neural differentiation, with applications in disease modeling and regenerative therapies.
April Pyle, University of California, Los Angeles, USA, studies muscle stem cells and human pluripotent stem cell biology to develop regenerative medicine strategies, including CRISPR-based therapies for neuromuscular diseases.
Ludovic Vallier, Berlin Institute of Health, Germany, uses pluripotent stem cells and organoids to study liver development and create cell-based therapies for metabolic and liver diseases.
With its unparalleled scientific expertise and steadfast commitment to publishing excellence, Stem Cell Reports continues to serve as the premier platform for groundbreaking research and thoughtful commentary that drive progress and shape the future of stem cell science.
Learn more about the Editorial Board and Editorial Team at Stem Cell Reports.
About Stem Cell Reports
Stem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. Stem Cell Reports is a Cell Press partner journal. Find the journal on X: @StemCellReports.
About ISSCR
With nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.